Works matching IS 03656233 AND DT 2022 AND VI 355 AND IP 3
Results: 13
Editorial Board: Arch Pharm (3/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 3, p. 1, doi. 10.1002/ardp.202270006
- Publication type:
- Article
Synthesis of novel 2‐acetamide‐5‐phenylthio‐1,3,4‐thiadiazole‐containing phenyl urea derivatives as potential VEGFR‐2 inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 3, p. 1, doi. 10.1002/ardp.202100397
- By:
- Publication type:
- Article
Insights into the chemistry and therapeutic potential of acrylonitrile derivatives.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 3, p. 1, doi. 10.1002/ardp.202100383
- By:
- Publication type:
- Article
Cover Picture: Arch Pharm (3/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 3, p. 1, doi. 10.1002/ardp.202270005
- Publication type:
- Article
1,5‐Benzodiazepines as a platform for the design of carbonic anhydrase inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 3, p. 1, doi. 10.1002/ardp.202100405
- By:
- Publication type:
- Article
Isobavachalcone suppresses the TRIF‐dependent signaling pathway of Toll‐like receptors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 3, p. 1, doi. 10.1002/ardp.202100404
- By:
- Publication type:
- Article
Design and synthesis of novel quinazolinone‐based fibrates as PPARα agonists with antihyperlipidemic activity.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 3, p. 1, doi. 10.1002/ardp.202100399
- By:
- Publication type:
- Article
Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO‐B dual inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 3, p. 1, doi. 10.1002/ardp.202100450
- By:
- Publication type:
- Article
Eugenol carbonate activity against Plasmodium falciparum, Leishmania braziliensis, and Trypanosoma cruzi.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 3, p. 1, doi. 10.1002/ardp.202100432
- By:
- Publication type:
- Article
Anticancer activity of novel 3‐(furan‐2‐yl)pyrazolyl and 3‐(thiophen‐2‐yl)pyrazolyl hybrid chalcones: Synthesis and in vitro studies.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 3, p. 1, doi. 10.1002/ardp.202100381
- By:
- Publication type:
- Article
Design and synthesis of novel chalcone derivatives and evaluation of their inhibitory activities against acetylcholinesterase.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 3, p. 1, doi. 10.1002/ardp.202100372
- By:
- Publication type:
- Article
In vitro and in silico studies of fluorinated 2,3‐disubstituted thiazolidinone‐pyrazoles as potential α‐amylase inhibitors and antioxidant agents.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 3, p. 1, doi. 10.1002/ardp.202100342
- By:
- Publication type:
- Article
Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID‐19.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 3, p. 1, doi. 10.1002/ardp.202100367
- By:
- Publication type:
- Article